HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo.

Abstract
Endothelin-1 (ET-1) and its receptors are overexpressed in human Kaposi's sarcoma lesions. Here we show that in human KS IMM cell line ET-1 increased secretion and activation of matrix-metalloproteinase-2 (MMP-2), -3, -7, -9 and -13, as well as of membrane-type 1-MMP (MT1-MMP). ET-1 and ET-3 also enhanced the expression of tissue inhibitor of MMP-2, essential for MT1-MMP-mediated MMP-2 activation. Combined addition of both ET(B) receptor (ET(B)R) and ET(A)R antagonists completely blocked the ET-1-induced MMP activity. By immunohistochemistry, we observed that ET-1 increased MMP-2 and MT1-MMP expression and their localization at the cell surface. Treatment with both antagonists resulted also in the suppression of ET-1-induced phosphorylation of focal adhesion proteins, FAK and paxillin, which are essentials for cell motility. ET-1 induced a dose-dependent enhancement in KS IMM cell migration and MMP-dependent invasiveness that were inhibited by ET-1 receptor antagonists. The small molecule, A-182086, an orally bioavailable ET(A/B)R antagonist, completely inhibited cell proliferation and tumor growth in KS IMM xenografts. These findings demonstrate that ET-1-driven autocrine loop is crucial for enhanced invasiveness of KS IMM cells and promote tumor growth in vivo. Such activities can be blocked by the ET(A/B)R antagonists, which may be effective anti-angiogenic and anti-tumor molecules for the treatment of Kaposi's sarcoma.
AuthorsLaura Rosanò, Francesca Spinella, Valeriana Di Castro, Maria Rita Nicotra, Adriana Albini, Pier Giorgio Natali, Anna Bagnato
JournalThe American journal of pathology (Am J Pathol) Vol. 163 Issue 2 Pg. 753-62 (Aug 2003) ISSN: 0002-9440 [Print] United States
PMID12875994 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Culture Media, Conditioned
  • Cytoskeletal Proteins
  • Endothelin Receptor Antagonists
  • Endothelin-1
  • Endothelin-3
  • PXN protein, human
  • Paxillin
  • Phosphoproteins
  • Pxn protein, mouse
  • Receptor, Endothelin A
  • Receptor, Endothelin B
  • Receptors, Endothelin
  • Tissue Inhibitor of Metalloproteinase-2
  • Protein-Tyrosine Kinases
  • Focal Adhesion Kinase 1
  • Focal Adhesion Protein-Tyrosine Kinases
  • PTK2 protein, human
  • Ptk2 protein, mouse
  • Matrix Metalloproteinases
Topics
  • Animals
  • Cell Division (physiology)
  • Cell Movement (physiology)
  • Cell Transplantation
  • Culture Media, Conditioned
  • Cytoskeletal Proteins (metabolism)
  • Endothelin Receptor Antagonists
  • Endothelin-1 (metabolism)
  • Endothelin-3 (metabolism)
  • Enzyme Activation
  • Female
  • Focal Adhesion Kinase 1
  • Focal Adhesion Protein-Tyrosine Kinases
  • Humans
  • Matrix Metalloproteinases (genetics, metabolism)
  • Mice
  • Mice, Nude
  • Paxillin
  • Phosphoproteins (metabolism)
  • Protein-Tyrosine Kinases (metabolism)
  • Receptor, Endothelin A
  • Receptor, Endothelin B
  • Receptors, Endothelin (metabolism)
  • Sarcoma, Kaposi (metabolism, pathology)
  • Tissue Inhibitor of Metalloproteinase-2 (metabolism)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: